Raf-1 kinase has been implicated in the induction of NFkB activity by serum growth factors, phorbol ester and PTK oncogenes. Here we show that Raf activation of NF-kB, as measured in reporter gene assays, occurs indirectly and requires the stress kinase cascade. The stress pathway presumably becomes activated through induction of an autocrine loop by activated Raf (Raf-BXB) as suramin, the tyrphostin AG1478 and a dominant negative mutant of the EGF-R blocked NFkB activation. Raf-BXB synergizes with SAPKs and a dominant negative mutant of SEK signi®cantly reduces activation of NF-kB consistent with a role of this signaling pathway in the activation of NF-kB.
Introduction
NF-kB/Rel transcription factor dimers are constitutively located within the nucleus of mature B cells whereas in other cell types this transcription factor complex is bound to cytoplasmic inhibitor proteins of the IkB family (Baeuerle and Baltimore, 1996; Wulczyn et al., 1996; Schreck et al., 1997) . Activation of cytoplasmic NF-kB requires degradation of IkBa, triggered by phosphorylation of serines 32 and 36 Baltimore, 1988, 1996; Wulczyn et al., 1996; Schreck et al., 1997) . Several kinases have been implicated in the phosphorylation of the serines at position 32 and 36. These protein kinases include p90rsk (Schouten et al., 1997) , a MEKK-1 activated IkB kinase (Lee et al., 1997) which is part of a bigger 700 kDa protein complex (Chen et al., 1996) and the recently identi®ed kinase IKK/Chuck (DiDonato et al., 1997; Regnier et al., 1997) .
Although several reports suggest that the PSK Raf-1 phosphorylates IkB (Li and Sedivy, 1993; Finco and Baldwin, 1993; Janosch et al., 1996) the sites of phosphorylation have not been identi®ed and indirect eects could not be excluded. Nevertheless, activtion of NF-kB-dependent transcription has been observed consistently following stimulation by Raf-1, PKC or PTK receptors (Bruder et al., 1992; Li and Sedivy, 1993; Finco and Baldwin, 1993; Flory et al., 1998) . In particular a dominant negative mutant of Raf-1, Raf-C4B (Bruder et al., 1992) , which interferes with Rasdependent activation of Raf-1, completely blocks NFkB activation by a variety of stimuli Li and Sedivy, 1993; Finco and Baldwin, 1993) . To study Raf dependent signaling pathways leading to NF-kB activation we analysed the induction of a 6xNF-kB element driven luciferase reporter construct by a constitutively active form of Raf, Raf BXB (Bruder et al., 1992) . Our experiments show that this pathway uses common Raf downstream signaling elements, but is also sensitive to inhibition by dominant negative mutants of Ras and Raf. These latter ®ndings suggest the involvement of membrane proximal events in the activation process. Presumably, the mechanism of Raf-mediated NF-kB activation includes membrane receptors because inhibitors of autocrine signaling loops block Raf-BXB eect. To test the potential involvement of protein kinase cascades that function in parallel to the Raf-MEK-MAPK pathway (Daum et al., 1994; Kyriakis and Avruch, 1996) in this process we examined the role of SAPKs and p38/RK (Han et al., 1994; Rouse et al., 1994) . Over-expression of SAPKa in 293 cells results in a strong transcriptional activation of the NF-kB response element, whereas no such eect is observed with p38RK. Furthermore, SAPK synergised with Raf in transcription activation. A potential role for stress kinase pathways in the Raf induced transcription activation is further supported by the ®nding that Raf-BXB induced NF-kB activation could be blocked by a dominant negative mutant of the JNK/SAPK activating kinase SEK-1 (Sanchez et al., 1994) .
Results
Activation of NF-kB dependent transcription by oncogenic Raf requires MEK/ERK and is blocked by dominant negative Raf-1 mutants Oncogenic Raf activates NF-kB in 293 cells (Figure 1a ) as detected in luciferase assays using a 6x NF-kB reporter gene and in EMSAs which used NIH3T3 cells that have no basal NF-kB activity (Figure 1b) . These data con®rm previously reported results (Bruder et al., 1992; Li and Sedivy, 1993; Finco and Baldwin, 1993; Flory et al., 1998) . Induction is sensitive to IkBa as cotransfection completely abolished this eect ( Figure  1a) .
We next investigated the signaling pathways employed by activated Raf in 293 cells for the stimulation of NF-kB. Figure 1a shows that a dominant negative mutant of ERK 2, C3 (Robbins et al., 1993) , which has been shown previously to completely block Raf-BXB induced ERK activation completely abolished transcription activation by Raf-BXB. This shows that classical components of Raf downstream signaling are required for NF-kB activation. We also included in our experiments a dominant negative mutant of Raf-1, Raf-C4B (Bruder et al., 1992) . Over-expression of this mutant blocks all Ras eectors by competing for Ras binding (Bruder et al., 1992; Zhang et al., 1993) . Surprisingly, Raf-BXB stimulation of the 6xNF-kB reporter was sensitive to the inhibitory eect of Raf-C4B (Figure 1a ). The speci®city of this inhibition was demonstrated by use of a mutant of Raf-C4B, Raf- Figure 1 (a) Activation of NF-kB dependent transcription by oncogenic Raf (Raf-BXB) is blocked by dominant negative mutants of ERK-2, Raf-1 (Raf-C4B) and Ras (Ras-N17). 0.6 mg of Raf-BXB and 0.5 mg 6xNF-kB luciferase reporter plasmid were cotransfected with 5 ± 7.5 mg of the plasmids indicated. These concentrations had given maximum inhibition in titration experiments. (Summary of results obtained in six independent experiments, three in the case of DN-ERK-2). Transfection of Raf-BXB routinely resulted in a 10 ± 20-fold induction of the reporter construct. Raf-C4BPM17 is a mutant of Raf-C4B with reduced ability to inhibit Ras dependent signaling. Luciferase activity was assayed 48 h after transfection. (b) NF-kB binding activity is increased in v-Raf transformed NIH3T3 cells. TNFa stimulation of control NIH3T3 cells was carried out for 2 h with 50 ng/ml. (c) Activation of NFkB involves autocrine mechanisms which are responsive towards the inhibitory action of suramin, the tyrphostin AG1478 or a dominant negative EGF-R mutant. Following transfection cells were kept in the presence of suramin (10 mM) or AG1478 (1 mM). 0.6 mg of the reporter plasmid were transfected together with 1 ± 2 mg of Raf-BXB. In the case of the DN-EGF-R 2.5 ± 5.0 mg of mutant DNA were used. Presence of the solvent DMSO (for AG1478) had no eect. Results represent mean values from three experiments. Potential downregulating eects of the dominant negative mutants and of suramin and the tyrphostin AG1478 were excluded by demonstrating that the expression levels of Raf-BXB protein were unaltered under these circumstances C4BPM17, which functions as a less eective Ras blocker (Bruder et al., 1992) . These results suggest that Raf-BXB stimulates NF-kB indirectly by a mechanism that involves Ras.
Ras is required for the activation of NF-kB dependent transactivation by Raf-BXB
To directly test for a role of Ras in Raf stimulated NFkB reporter gene expression the eect of the dominant negative Ras mutant N17Ras (Farnsworth and Feig, 1991) as well as oncogenic v-Ha-Ras were tested. Exchange of serine at codon 17 to asparagine of Ras results in preferential binding of GDP over GTP. It is speculated that the mutant protein retains high anity for the GDP/GTP exchange factor (GEF) and thereby suppresses activtion of endogenous Ras by competing for available GEF (Farnsworth and Feig, 1991) . As shown in Figure 1a over-expression of N17Ras in 293 cells completely blocks the Raf-BXB eect whereas oncogenic v-Ha-Ras showed a sevenfold increase in luciferase activity as compared to vector control (data not shown). These ®ndings are consistent with a role for Ras in Raf-mediated NF-kB activation.
Activation of NF-kB by oncogenic Raf involves autocrine mechanisms
As Raf does not directly aect Ras activity (Kyriakis et al., 1992) an indirect mechanism perhaps involving induction of an autocrine loop via TGFa and/or hbEGF has to be considered (Heidecker et al., 1989; McCarthy et al., 1995) . To evaluate this possibility suramin was added after transfection of the NF-kB reporter gene and Raf-BXB DNA. Previous studies have demonstrated the suitability of this drug to block activation of growth factor receptors in the plasma membrane by interfering with ligand-receptor interactions (Garret et al., 1984; Betsholtz et al., 1986) . As shown in Figure 1c presence of suramin signi®cantly inhibits the Raf-BXB eect on reporter gene expression. To directly test for involvement of the EGF receptor, the target of both TGFa and hbEGF, we used a dominant negative mutant of the EGF-R (Redemann et al., 1992) , comprizing the extracellular ligand binding domain of the receptor and a speci®c inhibitor of the receptor kinase, tyrphostin AG1478 (Fry et al., 1994; Levitzki and Gazit, 1995) . This agent has been shown to speci®cally block EGF-R autophosphorylation (Fry et al., 1994; Levitzki and Gazit, 1995) . Moreover, presence of a related substance, PD 153035, at a concentration of 0.3 micromolar completely reverted ligand induced transformation of Swiss 3T3 cells transfected with a human EGF-R (Fry et al., 1994) . As shown in Figure 1c presence of either the dominant negative EGF-receptor mutant or AG1478 blocked reporter gene expression in 293 cells (Figure 1c) . We conclude that Raf-BXB activation of the NF-kB dependent reporter involves induction of ligand(s) for the EGF-R.
Function of the SAPK/JNK cascade in the activation of NF-kB by Raf-BXB EGF-R is known not only to activate the mitogenic cascade but also the stress cascade especially when activated by hbEGF (McCarthy et al., 1995) . To determine whether elements of the JNK/SAPK or p38RK cascades could mediate NF-kB activation we tested the relevant eector kinases in transient assays. Whereas p38RK was not active in these assays ( Figure  2a) , overexpression of SAPKa induced the reporter gene (Figure 2a ). This induction could be further increased by coexpression with suboptimal levels of (Figure 2b ). SEK-1 is the physiological activator of SAPKa (Sanchez et al., 1994) . In order to test the requirement of the stress cascade for NF-kB activation we co-transfected the kinase dead inhibitory SEK-1 mutant (pEBG-SEK K-R ) together with Raf-BXB. pEBG-SEK K-R speci®cally blocked Raf-BXB induced NF-kB activation (Figure 3) .
Stimulation of cells with growth factors which activate Raf-1 results in a modest activation of SAPK (Kyriakis and Avruch, 1996) whereas expression of constitutively active forms of Raf in ®broblasts leads to pronounced and prolonged activation of stress kinases via an autocrine pathway (McCarthy et al., 1995; Kerkho and Rapp, 1997) . To test whether expression of Raf-BXB in 293 cells also leads to the activation of SAPK, an HA-tagged version of p54SAPKb was cotransfected with activated Raf (Raf-BXB) and SAPK activity was measured 48 h after transfection in an immune-complex kinase assay using GST-c-Jun as substrate. As shown in Figure 4 transfection of Raf-BXB resulted in increased SAPK activity. The degree of activation was comparable to the eect of anisomycin stimulation (data not shown). Furthermore, blockage of Raf-1 downstream signaling by cotransfection of a dominant negative mutant of MEK (pcDNA-LIDA) or Raf-1 (Raf-C4B) abolished JNK activation (Figure 4 ). These data thus show that Rafactivated pathways leading to activation of NF-kB overlap with those that mediate SAPK activation.
Material and methods

Plasmids
Constructs for the expression of constitutively active or dominant negative mutants of Raf, Ras, MEK and ERK2 have been described previously (Bruder et al., 1992; Farnsworth and Feig, 1991; Cowley et al., 1994; Robbins et al., 1993; Troppmair et al., 1994) . The dominant negative ERK2 C3 mutant was recloned into the KRSPA vector (Bruder et al., 1992) , the dominant negative MEK mutant (LIDA) was expressed from the vector pcDNA3 (Invitrogen). Plasmid pEBG-SEK (Sanchez et al., 1994) was kindly provided by Dr John Kyriakis. The kinase inactive mutant pEBG-SEK K-R was generated by Dr S Ludwig as previously described (Sanchez et al., 1994) . A dominant negative EGF-R mutant was kindly provided by Dr Axel Ullrich (Redemann et al., 1992) and recloned into the expression vector KRSPA (Bruder et al., 1992) . p38RK was a gift of Dr J Han and was recloned for these experiments into the expression vector KRSPA (Bruder et al., 1992) . Plasmids pMT2-SAPKa and b were a generous gift of Dr Jim Woodgett. The 6xNF-kB motif driven luciferase reporter construct and the IkBa expression construct (Haskill et al., 1991; Pahl and Baeurele, 1995) were provided by Dr Patrick Bauerle.
EMSA
Whole cell extracts were prepared and mobility shift assays (EMSAs) were performed as reported previously (Wirth and Baltimore, 1988; Lernbecher et al., 1993) .
Cells and transfection
293 human embryonic kidney cells and NIH3T3 ®broblasts were routinely grown in DMEM medium Figure 3 Raf-BXB induced activation of NF-kB dependent transcription can be blocked by a dominant negative Sek mutant (pEBG-SEK K-R ). 1 mg of Raf-BXB DNA was cotransfected with 5 mg of pEBG-SEK K-R or the vector control (pEBG). Luciferase activity was assayed 48 h after transfection. Summary of three experiments Figure 4 Raf-BXB induces activation of SAPKb in 293 cells via MEK-and Ras dependent pathways. 293 cells were transiently transfected with the DNAs indicated and activity of immunoprecipitated p54-HA-SAPKb was measured 48 h following transfection. pcDNA LIDA is a dominant negative mutant of MEK (Cowley et al., 1994) , Raf-C4B is a dominant negative mutant of Raf-1 (Bruder et al., 1992) . This experiment was performed twice with identical results
Stress kinase dependent NF-kB activation by Raf J Troppmair et al supplemented with 10% heat inactivated fetal calf serum, 2 mM L-glutamine and 100 U/ml of penicillin/streptomycin. Cells were seeded at a density of 2.5610 5 cells per 2 ml in six well plates and transfected 48 h later using the modi®ed calcium phosphate method (Chen and Ohayama, 1987) . 0.5 mg of reproter plasmid were transfected together with expression plasmids as indicated in the ®gure legends. Total amount of DNA transfected was kept constant by ®lling up with vector DNA. 6 ± 12 h after transfection precipitates were removed by washing with phosphate buered saline (PBS) and cells were refed with medium containing 0.3% serum. Forty-eight hours after transfection cells were washed with PBS and cell pellets were either shock frozen in liquid nitrogen and stored at 7808C or analysed directly.
Luciferase assay
Cell pellets were lysed in 400 ml of harvesting buer (50 mM Tris, 50 mM MES, pH 8.7, 1 mM DTT, 0.1% Triton X-100), precleared by centrifugation (15 000 g, 10 min at 48C), standardized for protein concentration and 50 ml of lysate were analysed together with 50 ml of assay buer (125 mM TRIS, 125 mM MES, pH 7.8, 25 mM magnesium acetate, 5 mM ATP) and 50 ml of Dluciferin (1 mM in 5 mM KHPO 4 , pH 7.8) in a luminometer (Microlumat LB 96P, Berthold AG, Germany).
SAPK assays and immunoblotting
An HA-tagged version of the pMT2-p54SAPKb was used for the analysis of SAPK activation in transiently transfected 293 cells. Immunoprecipitation and assay of kinase activity were performed as previously described for the analysis of ERK-1 using puri®ed GST-c-jun (1 ± 135) as substrate. Immunoblot analysis was carried out as described previously (Kerkho and Rapp, 1997) .
Discussion
Use of dominant negative Raf mutants has implicated Raf-1 PSK in the activation of NF-kB by a variety of stimuli including phorbol esters, serum, or PTK oncogenes Li and Sedivy, 1993; Finco and Baldwin, 1993) . Furthermore, transfection of oncogenic Raf as well as Ras resulted in enhanced transcription from NF-kB driven reporter constructs Finco and Baldwin, 1993; Finco et al., 1997) and transfection of gag-v-raf into NIH3T3 cells led to elevated nuclear levels of the p65 subunit of NF-kB (Li and Sedivy, 1993) . Since activation of NF-kB requires phosphorylation dependent degradation of its cytoplasmic inhibitor IkB several reports have addressed the question whether Raf itself might function as IkB kinase. These reports, however, have contradictory results. Whereas Raf was initially presented as an IkB kinase (Li and Sedivy, 1993) , subsequent work has pointed to an indirect mechanism involving casein kinase II (CKII), thought to be speci®cally Raf-associated (Janosch et al., 1996) . As none of the reports demonstrated phosphorylation of serines 32 and 36 on IkB which are critical for NF-kB activation other eector kinases might have intervened. The data in the present paper suggest a role for Raf-1 far more distal to the phosphorylation of IkB. Dominant negative mutants of Raf and Ras blocked activation of NF-kB dependent transcription by oncogenic Raf (Raf-BXB). We therefore tested the possible involvement of autocrine loops by using drugs that interfere with receptor signaling. Two compounds were used: suramin, which blocks ligand receptor interaction (Garret et al., 1984; Betsholtz et al., 1986) , and a speci®c inhibitor of the EGF-R PTK activity, the tyrphostin AG 1478 (Fry et al., 1994; Levitzki and Gazit, 1995) . Both substances eciently blocked Raf-BXB induced NF-kB activation. To further establish this point we employed a dominant negative mutant of the EGF-R. Expression of this mutant blocked Raf-BXB induced NF-kB reporter gene expression.
The signal from the EGF-R that mediates NF-kB activation is presumably propagated via Ras because dominant negative mutants of Ras as well as the Ras blocking mutant of Raf (Raf-C4B) inhibit induced reporter gene expression. We postulate therefore a branchpoint in signal transduction cascade from the EGF-R at the level of Ras. The role of Ras in regulation of stress kinase pathways is not fully understood. The most potent physiological activators of JNK/SAPK do not seem to require Ras (Kyriakis and Avruch, 1996) . On the other hand, overexpression of Ras in PC12 cells results in the activation of MEKK1, a kinase functioning in the activation cascade of JNK/SAPK, and stimulation of MEKK1 activity by EGF is blocked by a dominant negative Ras mutant . Nevertheless, comparison of Ras with two small GTPases of the Rho family, Rac and Cdc42, showed that Ras only poorly induced JNK/SAPK activity (Minden et al., 1995; Coso et al., 1995) . Experiments using dominant interfering alleles of Rac1 position Rac1 between Ha-Ras and MEKK1 in the signaling cascade leading from growth factor receptors and v-Src to JNK activation (Minden et al., 1994) . Such a position of Rac relative to Ras has also been shown for Ras transformation (Qui et al., 1995) . It is thus conceivable that Ras dependent activation of Rac connects receptor PTK signaling with the activation of JNK/SAPK. Ras requirement for the activation of JNK/SAPK has also been demonstrated for the cytoplasmic PTK Bcr-abl (Raitano et al., 1995) . Our results support published data suggesting a role of Ras in the activation of JNK/SAPK under conditions where PTKs function as activators.
Data relating to the role of stress kinase pathways in the activation of NF-kB are limited and controversial. Overexpression of MEKK1, an activator for the JNK/SAPK upstream kinase SEK/MKK4, induced transcription from the HIV-LTR as well as the IL2Ra promoter in a NF-kB dependent manner (Lee et al., 1997) . Furthermore, JNK1 synergized with MEKK1 in this process. More recently it has been demonstrated that addition of puri®ed MEKK1 protein to the multi subunit containing IkBa kinase complex (Lee et al., 1997) resulted in the activation of IkBa kinase in vitro and phosphorylation of IkBa on serines 32 and 36. MEKK1 induction of IkBa kinase activity was independent of ubiquitination and thus may constitute a separate pathway for NF-kB activation. However, this report failed to detect any requirement for MKK4 or JNK in the activation of NFkB. It is therefore possible that a separate MEKK1 initiated signaling pathway is involved. A MEKK1 independent pathway for the activation of NF-kB has been suggested by the analysis of TNF receptor I (TNF-RI) signaling (Liu et al., 1996) . Thus the precise link between JNK/SAPK pathways and signaling pathways leading to NF-kB activation remains to be determined.
